Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
10/2008
10/23/2008WO2008107362A3 Stabiliser and inhibitors of factor vii
10/23/2008WO2008093060A3 Peptides and their use
10/23/2008WO2008093058A3 Peptides and their use
10/23/2008WO2008049643A3 Gd2 peptide mimotopes for anticancer vaccination
10/23/2008US20080263687 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
10/23/2008US20080262211 Hepatitis-c virus type 4, 5 and 6
10/23/2008US20080262199 Kit comprising inhibitory peptide for use in reducing side effects of drug cessation
10/23/2008US20080262198 Tyrosine modified protein for use in as components of crosslinked fibers, emulsifiers and moleclular scaffolds
10/23/2008US20080261892 Angiogenesis; neovascularization; lyophilization; kits
10/23/2008US20080261862 Integrin mediates proliferative signal provided by CD23 to pre-B cells; immobilized rodent cells; drug screening; anticancer agents; antiinflammatory agents
10/23/2008US20080261311 Translation systems with orthogonal aminoacyl tRNA synthetase; membrane proteins
10/23/2008US20080261197 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection
10/23/2008US20080260847 polyglycolic acid or polylactic acid or glycolic acid-lactic acid copolymer as biocompatible polymer having dispersed therein an active agent such as exendin-4; antidiabetic agent
10/23/2008US20080260766 Epitopes, combined epitopes, use of epitopes or their combination, composition, uses of the composition, anti-HIV-1 prophylactic vaccines, therapeutic vaccines, method for the identification of epitopes and methods for treatment and prevention
10/23/2008US20080260762 HLA binding motifs and peptides and their uses
10/23/2008US20080260760 Nucleotide sequences coding prostate-specific antigen-derived peptide for use as vaccine inntreatment of urogenital cell proliferative disorders
10/23/2008US20080260759 Novel Mite Allergen
10/23/2008US20080260756 Peptide Inhibitors of iASPP
10/23/2008US20080260750 Polynucleotides Encoding Acetylcholine-Gated Chloride Channel Subunits of Caenorhabditis Elegans
10/23/2008US20080260748 Desmocollin 2 (DSC2) specific immunoglobulin for use in prevention and treatment of cell proliferative disorders
10/23/2008US20080260689 Mixture comprising Interleukin receptor amino acid sequences for use in developing vaccine for prevention and treatment of autoimmune diseases; genetic vaccines
10/23/2008CA2683454A1 Tem8 peptides and vaccines comprising the same
10/22/2008EP1983050A1 Peptides binding to the Lck-SH3 and Hck-SH3 domains
10/22/2008EP1983049A1 Peptides binding to the Lck-SH3 and Hck-SH3 domains
10/22/2008EP1982992A1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector
10/22/2008EP1982728A1 Peptide derived from hepatitis c virus
10/22/2008EP1981974A2 Compositions and methods for treating lysosomal storage diseases
10/22/2008EP1981900A2 Novel compounds
10/22/2008EP1814902B1 Cyclosporine analogue
10/22/2008EP1560590B1 Synthetic complementary peptides and ophthalmologic uses thereof
10/22/2008EP1535070A4 Nano-sized optical fluorescence labels and uses thereof
10/22/2008EP1385982B1 Methods and means for detecting enzymatic cleavage and linkage reactions
10/22/2008EP1375518B1 Anti-osteopontin antibody and use thereof
10/22/2008EP1368371B1 Transfection complexes
10/22/2008CN101289500A Long lasting fusion peptide inhibitor of viral infection
10/22/2008CN101289499A Cyclic peptide with -Ile-Sta-Sta-Pro- residue segment and used as immunity inhibitor and synthetic process thereof
10/22/2008CN101289498A Cyclic peptide with -val-sta-leu- residue segment and used as immunity inhibitor and synthetic process thereof
10/22/2008CN101289497A Cyclic peptide with -Ile-Sta-Sta-Tyr- residue segment and used as immunity inhibitor and synthetic process thereof
10/22/2008CN101289496A Epitope screening method capable of exciting anti-mycobacterium tuberculosis protective immunological reaction of body and uses
10/22/2008CN101289495A Selenium-containing pentapeptide compounds and uses thereof
10/22/2008CN100427502C Antineoplastic oligopeptide and its preparation method and application
10/22/2008CN100427139C Water-soluble shps as novel alkylating agents
10/21/2008US7439345 Supramolecular pairing system, its preparation and use
10/21/2008US7439329 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase
10/21/2008US7439323 Cysteine-containing peptides having antioxidant properties
10/21/2008US7439319 Selective substrates for matrix metalloproteinases
10/21/2008US7439231 Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof
10/21/2008US7439226 Serine protease inhibitors
10/21/2008US7439225 Culturing Rhodococcus; antitubercular agents; side effect reduction
10/21/2008US7439063 Providing acute neuroprotection by contacting neuronal cells with erythropoietin or active fragment or analog thereof close to or subsequent to time of excitatory insult and contacting cells with insulin-like growth factor, thereby producing synergistic acute neuroprotective effect; Alzheimer's disease
10/21/2008US7438917 Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes
10/21/2008US7438890 Binding peptides for carcinoembryonic antigen (CEA)
10/21/2008CA2247998C Fragments of cr1 and their use
10/16/2008WO2008123180A1 Method for detection of target substance, and tag, dna, vector, probe and detection kit for use in the method
10/16/2008WO2008122089A1 Method of purifying recombinant peptides by selective precipitation
10/16/2008US20080256649 Insect hydrolase for use as tool in identifying modulators which prevent mosquito propagation; genetic detection of resistance to organophosphorus and/or carbamates pesticides
10/16/2008US20080255039 Peptide which is part of epitope in human IL-15 responsible for high-affinity binding of IL-15 to IL-15Ralpha chain, characterized in that it has sequence of region of human mature wild-type IL-15 from L44 to L52, or sequence of region of human mature wild-type IL-15 from E64 to I68 or from E64 to L69
10/16/2008US20080254546 Arsenic complexes; transmetallization
10/16/2008US20080254506 Claudin polypeptides
10/15/2008EP1979375A2 Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae
10/15/2008EP1979374A2 Template-fixed peptidomimetics
10/15/2008EP1979373A2 Proline-rich peptides, pharmaceutical composition, use of one or more peptides and method of treatment
10/15/2008EP1978988A2 Peptide-based regulation of gap junctions
10/15/2008EP1663118A4 Peptide-based conditioners and colorants for hair, skin, and nails
10/15/2008EP1466614B1 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon
10/15/2008EP1272515B1 Immunoregulator
10/15/2008CN101287988A Methods and compositions for diagnosis and treatment of influenza
10/15/2008CN101287749A Peptides and compounds that bind to a receptor
10/15/2008CN101287748A Compositions and methods for fusion protein separation
10/15/2008CN101287747A GDNF derived peptides
10/15/2008CN101287485A Anti-angiogenic compounds
10/15/2008CN101287484A Binding agents which inhibit myostatin
10/15/2008CN101284871A Cyclic peptides with ¿CPro-Sta-Tyr- residue fragment as immunity inhibitor and synthesis process thereof
10/15/2008CN101284870A Polypeptides of anti-measles virus and human immunodeficiency virus and use
10/15/2008CN101284869A Antiviral polypeptides and use
10/15/2008CN101284868A Peptides hydration salt compounds and stereoisomers thereof
10/15/2008CN101284867A Anti-oxidation peptide from bee milk
10/15/2008CN101284866A Anti-oxidation peptide from bee milk
10/15/2008CN101284865A New compound and its medicine use
10/14/2008US7435791 Preparing amino acid sequences in organic solvent or mixture of organic solvents; in vitro translation; mimetics
10/14/2008US7435790 Dihydroxypropyl cysteine peptide and agent containing this peptide
10/14/2008US7435721 Of pestviruses as drug delivery devices for type-specific diagnosis of infection, for eliciting antibiotic activity, and for transport of substances into a cell
10/14/2008US7435718 CXCR4 antagonist treatment of hematopoietic cells
10/14/2008US7435716 Compounds pharmaceutical compositions and methods for treatment of bacteremia and/or septicemia
10/09/2008WO2008120006A2 Diagnostic assay
10/09/2008WO2008119208A1 N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase iv and the pharmaceutical uses thereof
10/09/2008WO2008067158A3 METHOD TO PROMOTE HAIR GROWTH AND/OR DELAY OR TREAT HAIR LOSS BY ADMINISTERING A TGF-β ANTAGONIST OR INHIBITOR
10/09/2008WO2007130743A3 Capreomycin derivatives and their use as antibacterials
10/09/2008US20080250511 Nucleotide sequences for use as screening tools in diagnosis of anxiety and/or depressive disorder
10/09/2008US20080249284 Gene encoding labyrinthin, a marker for cancer
10/09/2008US20080249283 Human leukocyte antigen amino acid sequences which recognize hepatitis viral epitopes; vaccine development; viricides
10/09/2008US20080249027 Heptapeptide having the sequence of CHEASQC; Multiple Sclerosis, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis
10/09/2008US20080249026 PEPTIDES AND THEIR UTILITY IN MODULATION OF BEHAVIOR OF CELLS EXPRESSING alpha3beta1 INTEGRINS
10/09/2008US20080249025 Peptide fragments of p21; antiproliferative agents
10/09/2008US20080249024 Peptides facilitating or inhibiting a nterograde transport
10/09/2008US20080249023 Topical, intravenous, or iontophoretic administration of a phosphate buffered polypeptide sequence, TRKKLFHIFHATIRSR (PAD-1.17); cutaneous or pulmonary presenting anthrax antidotes; biological warfare
10/09/2008US20080249021 Biologically active peptides and their use for repairing injured nerves
10/09/2008US20080249009 ApM-1 and related proteins to influence partitioning of dietary lipids between liver and peripheral tissues; reduce free fatty acids in obese individuals; decrease body weight; atherosclerosis; insulin resistance; hypertension, microangiopathic lesions
10/09/2008US20080248527 Binding amino acid sequences for use in targeting stains on textiles; enhancing cleaning performance of detergents
10/09/2008US20080248500 Apolipoprotein A-II Isoform As A Biomarker For Prostate Cancer
1 ... 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 ... 423